Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.84 - $1.43 $25,200 - $42,900
30,000 Added 19.34%
185,100 $216,000
Q2 2023

Aug 14, 2023

SELL
$0.83 - $1.12 $62,250 - $84,000
-75,000 Reduced 32.59%
155,100 $136,000
Q1 2023

May 15, 2023

BUY
$0.91 - $1.69 $5,096 - $9,464
5,600 Added 2.49%
230,100 $237,000
Q4 2022

Feb 14, 2023

BUY
$1.09 - $2.04 $27,250 - $51,000
25,000 Added 12.53%
224,500 $282,000
Q3 2022

Nov 14, 2022

BUY
$1.55 - $3.01 $155,000 - $301,000
100,000 Added 100.5%
199,500 $321,000
Q2 2022

Aug 15, 2022

SELL
$1.39 - $3.12 $69,500 - $156,000
-50,000 Reduced 33.44%
99,500 $196,000
Q1 2022

May 16, 2022

BUY
$2.6 - $4.17 $388,700 - $623,415
149,500 New
149,500 $454,000

Others Institutions Holding FIXX

About Homology Medicines, Inc.


  • Ticker FIXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 57,402,000
  • Description
  • Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...
More about FIXX
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.